COVID-19: increases in contribution lower prescription drug insurance

COVID-19: des hausses de cotisation moindres pour l’assurance médicaments

The increase in contribution of the people registered for the public prescription drug insurance plan of Quebec (RPAM) will be reduced to take into account the extra pressure generated by the COVID-19, announced the provincial government on Monday.

Thus, even if the number of persons insured, the amount of the drug purchased and the price thereof increase, the increase in contributions will be lower than what it should have been in normal times, says the Régie de l’assurance maladie du Québec (RAMQ), by way of a press release.

“This approach helps maintain reasonable and equitable access to the medications required by the state of health of the quebec population,” says-t-on.

For example, the maximum annual premium to be paid to Revenu Québec when filing the return of income will be increased from 636 to $ 648 $, an increase of 1.9 %.

However, this increase will be less than it would have had to be (5%, depending on the adjustment rate provided for) on account of job losses and decreases in revenues generated by the context of the pandemic, indicates the RAMQ.

Also, the cost of the monthly deductible and co-insurance will not be increased. Their increase would have been 7 %, taking into account the rate adjustment provided, also specifies the RAMQ.

These new rates will be effective from 1 July to 31 December 2020 and will be subject to change for the period 1 January to 30 June 2021.

The RPAM covers 3.7 million people in Quebec (1% increase) of which, almost all of those aged 65 years or more.

Share Button